abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
SG&A Expenses
$9.95M
TTM · Period ending: · USD
HQL SG&A Expenses
Latest reported$9.95Mperiod ending
Latest reported$9.95Mperiod ending
HQL SG&A Expenses ($0.00 → $9.95M)
Annual SG&A Expenses
High-resolution chart · PNG
HQL sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 743,171 | |
| 1,332,115 | |
| 903,138 | |
| 1,076,700 | |
| 844,018 | |
| 751,317 | |
| 5,319,624 | |
| 5,592,934 | |
| 991,511 | |
| -2 | |
| 6,044,830 | |
| 4,642,565 | |
| 3,686,717 | |
| 3,427,918 | |
| 1,150,000 | |
| 630,000 | |
| 590,000 | |
| 680,000 | |
| 720,000 | |
| 550,000 | |
| 510,000 | |
| 530,000 | |
| 450,000 | |
| 470,000 | |
| 340,000 | |
| 230,000 | |
| 190,000 | |
| 0 |